Topical steroid therapy in skin disease. A panel discussion.
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy; D003875:Drug Eruptions / Q000517:prevention & control; D004485:Eczema / Q000188:drug therapy; D005938:Glucocorticoids; D006801:Humans; D006854:Hydrocortisone; D009779:Occlusive Dressings; D014677:Pharmaceutical Vehicles; D011565:Psoriasis / Q000188:drug therapy; D012869:Skin Absorption; D012871:Skin Diseases / Q000188:drug therapy*; D014382:Tuberculosis, Cutaneous / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014677:Pharmaceutical Vehicles; D006854:Hydrocortisone